{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:59:56Z","timestamp":1790369996828,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-442-002-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-442-002-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017480","name":"Chang Bing Show Chwan Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["SRD-113027"],"award-info":[{"award-number":["SRD-113027"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["113-SCN-0007"],"award-info":[{"award-number":["113-SCN-0007"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-039-063-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-039-063-MY3"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.04.084","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:00:07Z","timestamp":1777842007000},"page":"834-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Palbociclib Enhances Radiation Therapy Efficacy by Promoting Apoptosis and Immune Modulation in Oral Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"126","author":[{"given":"Peng-Yi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Feng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Lan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Tsang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2153-340X","authenticated-orcid":false,"given":"Fei-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.04.084_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: State of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18556","article-title":"Hypomethylation-associated SOX11 upregulation promotes oncogenesis via the PI3K\/AKT pathway in olp-associated OSCC","volume":"28","author":"Liu","year":"2024","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1476-4598-9-144","article-title":"Glycogen synthase kinase 3 beta: can it be a target for oral cancer","volume":"9","author":"Mishra","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0004","first-page":"775","article-title":"Radiotherapy and the cellular DNA damage response: Current and future perspectives on head and neck cancer treatment","volume":"3","author":"Fabbrizi","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2478\/raon-2021-0041","article-title":"Definitive radiotherapy for squamous cell carcinoma of the oral cavity: A single-institution experience","volume":"55","author":"Lang","year":"2021","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.radonc.2020.08.013","article-title":"Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach","volume":"154","author":"Hosni","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0007","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","article-title":"Cyclin D-CDK4,6 drives cell-cycle progression via the retinoblastoma protein's c-terminal helix","volume":"74","author":"Topacio","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0008","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/ijms26052197","article-title":"Dinaciclib interrupts cell cycle and induces apoptosis in oral squamous cell carcinoma: Mechanistic insights and therapeutic potential","volume":"26","author":"Oner","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0009","doi-asserted-by":"crossref","first-page":"264","DOI":"10.20892\/j.issn.2095-3941.2018.0257","article-title":"Effects of palbociclib on oral squamous cell carcinoma and the role of PI3KCA in conferring resistance","volume":"16","author":"Zainal","year":"2019","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118340","article-title":"A brain-penetrant CDK 4\/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma","volume":"189","author":"Mekonnen","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0011","doi-asserted-by":"crossref","first-page":"713","DOI":"10.21873\/anticanres.13167","article-title":"CDK4\/6 inhibitor LEE011 is a potential radiation-sensitizer in head and neck squamous cell carcinoma: An in vitro study","volume":"39","author":"Tai","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0012","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2019.06.2531","article-title":"Inhibition of CDK4\/CDK6 enhances radiosensitivity of hpv negative head and neck squamous cell carcinomas","volume":"105","author":"G\u00f6ttgens","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0013","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/cancers15072005","article-title":"CDK4\/6 inhibition induces senescence and enhances radiation response by disabling DNA damage repair in oral cavity squamous cell carcinoma","volume":"15","author":"Shrivastava","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0014","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/1078-0432.CCR-23-2303","article-title":"A phase I study of the CDK4\/6 inhibitor palbociclib in combination with cetuximab and radiotherapy for locally advanced head and neck squamous cell carcinoma","volume":"30","author":"Ngamphaiboon","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0015","article-title":"A critical review on exploring tumor microenvironment's impacts on radioresistance","volume":"17","author":"Houshyari","year":"2024","journal-title":"J Radiat Res Appl Sci"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102916","article-title":"Tumor microenvironment as a regulator of radiation therapy: new insights into stromal-mediated radioresistance","volume":"12","author":"Krisnawan","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104010","article-title":"Immune effects of CDK4\/6 inhibitors in patients with HR(+)\/HER2(-) metastatic breast cancer: relief from immunosuppression is associated with clinical response","volume":"79","author":"Scirocchi","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0018","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.21873\/anticanres.16586","article-title":"Imipramine suppresses tumor growth and induces apoptosis in oral squamous cell carcinoma: targeting multiple processes and signaling pathways","volume":"43","author":"Hsu","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0019","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.21873\/anticanres.14695","article-title":"Anticancer efficacy and mechanism of amentoflavone for sensitizing oral squamous cell carcinoma to cisplatin","volume":"40","author":"Chen","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib50","first-page":"895","article-title":"Synergistic interaction of anticancer agents: a cellular perspective","volume":"59","author":"Valeriote","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib51","first-page":"2177","article-title":"Chronology of combined chemotherapy (5FU) and radiotherapy. I. In vitro study","volume":"13","author":"Carpentier","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","article-title":"The combination index (CI < 1) as the definition of synergism and of synergy claims","volume":"7","author":"Chou","year":"2018","journal-title":"Synergy"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2022.09.060","article-title":"Lenvatinib synergistically promotes radiation therapy in hepatocellular carcinoma by inhibiting SRC\/STAT3\/NF-\u03baB-mediated epithelial-mesenchymal transition and metastasis","volume":"115","author":"Weng","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12935-024-03597-7","article-title":"Mechanistic insights of lenvatinib: Enhancing cisplatin sensitivity, inducing apoptosis, and suppressing metastasis in bladder cancer cells through EGFR\/ERK\/p38\/nf-\u03bab signaling inactivation","volume":"25","author":"Chiang","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0022","first-page":"146","article-title":"Intramucosal inoculation of squamous cell carcinoma cells in mice for tumor immune profiling and treatment response assessment","author":"Oweida","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0023","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.21873\/invivo.12157","article-title":"Therapeutic efficacy and inhibitory mechanism of regorafenib combined with radiation in colorectal cancer","volume":"34","author":"Liu","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0024","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0025","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204203","article-title":"Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model","volume":"41","author":"Tyan","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0026","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112661","article-title":"Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma","volume":"147","author":"Chiang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0028","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-025-03336-4","article-title":"Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy","volume":"44","author":"Yueh","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0029","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.21873\/invivo.13296","article-title":"Humanized PD-1 knock-in mice reveal nivolumab's inhibitory effects on glioblastoma tumor progression in vivo","volume":"37","author":"Chiang","year":"2023","journal-title":"In Vivo"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0030","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.21873\/anticanres.17669","article-title":"Amentoflavone enhances the anti-tumor activity of regorafenib by promoting apoptosis and inhibiting NF-\u03baB-mediated metastasis in hepatocellular carcinoma","volume":"45","author":"Lin","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0031","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.21873\/anticanres.17662","article-title":"Magnolol suppresses osteosarcoma progression via apoptosis induction and EGFR\/Akt pathway inactivation in a U-2 OS xenograft model","volume":"45","author":"Li","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.33","article-title":"Combination of palbociclib and radiotherapy for glioblastoma","volume":"3","author":"Whittaker","year":"2017","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0033","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00262-011-1008-4","article-title":"Targeting the extrinsic apoptosis signaling pathway for cancer therapy","volume":"60","author":"Sayers","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0034","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118688","article-title":"Targeting apoptotic caspases in cancer","volume":"1867","author":"Boice","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643291","article-title":"Immunotherapy goes local: the central role of lymph nodes in driving tumor infiltration and efficacy","volume":"12","author":"van Pul","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0038","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0039","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13046-020-01693-w","article-title":"Cdk4\/6 inhibitors: a novel strategy for tumor radiosensitization","volume":"39","author":"Yang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijrobp.2008.06.1902","article-title":"Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis","volume":"72","author":"Maduro","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopha.2011.09.011","article-title":"Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-\u039ab expression in vitro and in vivo","volume":"66","author":"Kuo","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0042","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0043","article-title":"Palbociclib, a selective CDK4\/6 inhibitor, administered before and after chemoradiotherapy for human papillomavirus-negative, locally advanced head and neck squamous cell carcinoma: a single-arm, phase II trial","volume":"9","author":"Oppelt","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0044","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon\u2013dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0045","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0046","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijrobp.2021.09.010","article-title":"Boosting the abscopal effect using immunogenic biomaterials with varying radiation therapy field sizes","volume":"112","author":"Yasmin-Karim","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0047","article-title":"T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0048","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cas.15195","article-title":"Circulating na\u00efve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma","volume":"113","author":"Takahashi","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2026.04.084_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110288","article-title":"Prunella vulgaris l. Attenuates experimental autoimmune thyroiditis by inducing indoleamine 2,3-dioxygenase 1 expression and regulatory T cell expansion","volume":"128","author":"Qiu","year":"2020","journal-title":"Biomed Pharmacother"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626006863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626006863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:06:36Z","timestamp":1790366796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626006863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626006863"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.04.084","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palbociclib Enhances Radiation Therapy Efficacy by Promoting Apoptosis and Immune Modulation in Oral Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}